Arcadia Biosciences, Inc.
RKDA
$0.47
$0.000.23%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -47.72% | -362.45% | 66.77% | 13.04% | -11.10% |
| Total Depreciation and Amortization | -96.41% | -93.12% | -79.87% | -60.42% | -48.92% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 380.65% | 184.69% | -32.49% | 92.17% | 134.33% |
| Change in Net Operating Assets | 154.49% | 118.92% | 98.20% | 54.15% | 10.97% |
| Cash from Operations | 66.55% | 46.91% | 50.77% | 47.36% | 40.28% |
| Capital Expenditure | -- | -- | -- | 100.00% | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -101.93% | -28.33% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -100.00% | -96.68% | -89.32% | -26.94% | -26.94% |
| Cash from Investing | -100.00% | -96.81% | -89.78% | -33.08% | -26.76% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 67,488.89% | -88.89% | -33.33% | -33.33% | -25.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 59,211.11% | 19,844.44% | -33.33% | -33.33% | -25.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 167.88% | -1,295.57% | -75.00% | 57.81% | 48.27% |